Literature DB >> 22717599

Incidence and prevalence of multiple sclerosis in southeastern Iran.

Ali Moghtaderi1, Forough Rakhshanizadeh, Shahryar Shahraki-Ibrahimi.   

Abstract

BACKGROUND: Based on data available, Iran is located in a low risk area for multiple sclerosis (MS). The objective of the current study is to determine the age and sex adjusted prevalence and incidence of MS in southeastern Iran.
METHODS: This cross-sectional case register study was conducted from January to August 2010. Considering that MS affects people aged between 16 and 50 years, we intended to find the incidence and prevalence of MS during this age range. Since all cases in this area are referred to our university hospital for confirmation of diagnosis, misdiagnosis is rare. Population data, based on the censuses carried out in 1996 and 2006, were obtained from the Iranian Bureau of Statistics to determine the number of people at risk.
RESULTS: Totally 206 patients were identified according to the McDonald criteria. In 2009 the age-adjusted prevalence and incidence rates of MS for 16-50 year-old adults were 13.96 and 2.67 per 100,000 persons, respectively. Based on those values; the female to male ratio was 2.18. Between 2006 and 2009, the incidence rates increased 2.4 and 2.7 times in women and men, respectively. In 2009, the prevalence rates among the age ranges of <15, 16-35, 36-50 and ≥51 years were 1.44, 14.34, 12.24 and 1.45 per 100,000 persons, respectively, and the relapsing-remitting type of MS was the most prevalent form (65.8%).
CONCLUSION: According to the Kurtzke geographical distribution, the authors conclude that the prevalence of MS in southeastern Iran is in the intermediate range, and the incidence rate is showing a faster growth rate, compared to previous years.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22717599     DOI: 10.1016/j.clineuro.2012.05.032

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  20 in total

1.  Multiple sclerosis and environmental risk factors: a case-control study in Iran.

Authors:  Maryam Abbasi; Seyed Massood Nabavi; Seyed Mohammad Fereshtehnejad; Nikan Zerafat Jou; Iman Ansari; Vahid Shayegannejad; Seyed Ehsan Mohammadianinejad; Mahdi Farhoudi; Abbas Noorian; Nazanin Razazian; Mahmoud Abedini; Fardin Faraji
Journal:  Neurol Sci       Date:  2017-08-10       Impact factor: 3.307

2.  Vitamin D Receptor Gene Polymorphism and the Risk of Multiple Sclerosis in South Eastern of Iran.

Authors:  Mehrnaz Narooie-Nejad; Maryam Moossavi; Adam Torkamanzehi; Ali Moghtaderi; Saeedeh Salimi
Journal:  J Mol Neurosci       Date:  2015-02-18       Impact factor: 3.444

3.  Cultural Adaptation, Validity, and Factor Structure of the Jalowiec Coping Scale in Iranian Women with Multiple Sclerosis: Which Coping Strategies Are Most Common and Effective?

Authors:  Mohsen Saffari; Hormoz Sanaeinasab; Mahrokh Hashempour; Amir H Pakpour; Jesus F Lovera; Saad Al Shohaib
Journal:  Int J MS Care       Date:  2017 Jul-Aug

4.  Relationship between the use of electronic devices and susceptibility to multiple sclerosis.

Authors:  Fatemeh Khaki-Khatibi; Alireza Nourazarian; Fatemeh Ahmadi; Mehdi Farhoudi; Daryoush Savadi-Oskouei; Mahya Pourostadi; Mohammad Asgharzadeh
Journal:  Cogn Neurodyn       Date:  2019-02-02       Impact factor: 5.082

5.  Prevalence and predictors of depression in Iranian patients with multiple sclerosis: a population-based study.

Authors:  Seyed Mohammad Seyed Saadat; Mozaffar Hosseininezhad; Babak Bakhshayesh; Seyedeh Nastaran Seyed Saadat; Seyedeh Parand Nabizadeh
Journal:  Neurol Sci       Date:  2013-12-10       Impact factor: 3.307

6.  The Multiple Sclerosis Self-Management Scale-Revised (MSSM-R): Persian Version and Psychometric Analysis.

Authors:  Sajjad Saadat; Mohammad Bagher Kajbaf; Mehrdad Kalantari; Mozaffar Hosseininezhad
Journal:  Int J MS Care       Date:  2020 Jan-Feb

7.  Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis.

Authors:  Nourollah Ramroodi; Nima Sanadgol; Zohre Ganjali; Abbas Ali Niazi; Vida Sarabandi; Ali Moghtaderi
Journal:  J Pathog       Date:  2013-01-22

8.  Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.

Authors:  Masoud Nikanfar; Ali Akbar Taheri-Aghdam; Maria Yazdani; Sheida Shaafi; Nooshin Masoudian; Hossein Akbari; Parisa Youhanaee; Hamzeh Abbaszadeh
Journal:  Iran J Neurol       Date:  2015-01-05

9.  Prevalence and Incidence of Multiple Sclerosis in Fars Province, Southern Iran.

Authors:  Sadegh Izadi; Ali Reza Nikseresht; Maryam Poursadeghfard; Afshin Borhanihaghighi; Seyyed Taghi Heydari
Journal:  Iran J Med Sci       Date:  2015-09

10.  Prediction of Multiple sclerosis disease using machine learning classifiers: a comparative study.

Authors:  Sonia Darvishi; Omid Hamidi; Jalal Poorolajal
Journal:  J Prev Med Hyg       Date:  2021-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.